Switch to: References

Add citations

You must login to add citations.
  1. When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research.Edward Jacobs, Ashleigh Murphy-Beiner, Ian Rouiller, David Nutt & Meg J. Spriggs - 2023 - Neuroethics 17 (1):1-17.
    The ethical value—and to some scholars, necessity—of providing trial patients with post-trial access (PTA) to an investigational drug has been subject to significant attention in the field of research ethics. Although no consensus has emerged, it seems clear that, in some trial contexts, various factors make PTA particularly appropriate. We outline the atypical aspects of psychedelic clinical trials that support the case for introducing the provision of PTA within research in this field, including the broader legal status of psychedelics, the (...)
    Download  
     
    Export citation  
     
    Bookmark  
  • Below the Surface of Clinical Ethics.J. Clint Parker - 2023 - Journal of Medicine and Philosophy 48 (1):1-11.
    Often lurking below the surface of many clinical ethical issues are questions regarding background metaphysical, epistemological, meta-ethical, and political beliefs. In this issue, authors critically examine the effects of background beliefs on conscientious objection, explore ethical issues through the lenses of particular theoretical approaches like pragmatism and intersectional theory, rigorously explore the basic concepts at play within the patient safety movement, offer new theoretical approaches to old problems involving decision making for patients with dementia, explicate and explore the problems and (...)
    Download  
     
    Export citation  
     
    Bookmark